Intratumoural-infiltrating CD4 + and FOXP3 + T cells as strong positive predictive markers for the prognosis of resectable colorectal cancer

CD3 +  and CD8 + T-cell infiltration were reported as positive predictive markers of survival in colorectal cancer (CRC) patients. Here, we demonstrate the prognostic significance of CD4 + and FOXP3 + T-cell densities in CRC. We quantified the intratumoural densities of CD3 + , CD8 + , CD4 +  and FOXP3 + T cells by immunohistochemistry and digital pathology in 342 CRC patients who underwent curative resection. Microsatellite instability was also assessed in 322 specimens. Patient demographics, clinicopathological features and survival rates were analysed. High CD3 + , CD4 +  and FOXP3 + T-cell densities were associated with improved relapse-free survival (RFS); high CD8 + , CD4 +  and FOXP3 + T-cell densities were associated with improved disease-specific survival (DSS). Patients with low CD4 + and low FOXP3 + T-cell densities exhibited extremely poor prognoses. T stage, vascular/lymphatic invasion and CD4 + T-cell density were independent prognostic indicators for DSS. The distributions of CD4 + and FOXP3 + T-cell densities were not significantly different between the high microsatellite instability group and other groups, in contrast to those of CD3 + and CD8 + T-cell densities. Intratumoural CD4 + T-cell density and combined CD4 + and FOXP3 + T-cell densities were stronger prognostic indicators than other clinicopathological features. These results may facilitate the establishment of novel prognostic factors and therapeutic strategies for CRC.

• Publication year

  2019

• Venue

  British Journal of Cancer

• Publication date

  2019-09-06

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/s41416-019-0559-6PMID 31488881PMCID 6889292
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Advances in cancer immunotherapy for gastroenterological malignancy

  2018cited by this paper
• International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study.

  2018cited by this paper
• Recent advances of neoadjuvant chemoradiotherapy in rectal cancer: Future treatment perspectives

  2018cited by this paper
• Current status of immunotherapy against gastrointestinal cancers and its biomarkers: Perspective for precision immunotherapy

  2018cited by this paper
• Prognostic value of tumor-infiltrating lymphocytes differs depending on histological type and smoking habit in completely resected non-small-cell lung cancer.

  2016cited by this paper
• Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability.

  2016cited by this paper
• Two FOXP3+CD4+ T cell subpopulations distinctly control the prognosis of colorectal cancers

  2016cited by this paper
• Personalizing colon cancer adjuvant therapy: selecting optimal treatments for individual patients.

  2015cited by this paper
• The Consensus Molecular Subtypes of Colorectal Cancer

  2015cited by this paper
• Prognostic Value of Tumor-Infiltrating FoxP3+ T Cells in Gastrointestinal Cancers: A Meta Analysis

  2014cited by this paper
• Regulatory T cells in cancer immunotherapy.

  2014cited by this paper
• Tumour‐Infiltrating FoxP3+ and IL‐17‐Producing T Cells Affect the Progression and Prognosis of Gallbladder Carcinoma after Surgery

  2013cited by this paper
• Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours

  2013cited by this paper
• Differential pattern and prognostic significance of CD4+, FOXP3+ and IL-17+ tumor infiltrating lymphocytes in ductal and lobular breast cancers

  2012cited by this paper
• Has the new TNM classification for colorectal cancer improved care?

  2012cited by this paper
• Integrated analysis of molecular and clinical prognostic factors in stage II/III colon cancer.

  2012cited by this paper
• The immune contexture in human tumours: impact on clinical outcome

  2012cited by this paper
• Predictive Biomarkers and Personalized Medicine MutationPro fi ling andMicrosatellite Instability in Stage II and III Colon Cancer : An Assessment of Their Prognostic and Oxaliplatin Predictive Value

  2012cited by this paper
• Mutation Profiling and Microsatellite Instability in Stage II and III Colon Cancer: An Assessment of Their Prognostic and Oxaliplatin Predictive Value

  2012cited by this paper
• ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making.

  2012cited by this paper
• Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction.

  2011cited by this paper
• Global cancer statistics

  2011cited by this paper
• Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer.

  2011cited by this paper
• Tumour‐infiltrating T‐cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review

  2010cited by this paper
• Colorectal cancer

  2010cited by this paper
• Colorectal cancer – Authors' reply

  2010cited by this paper
• Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

  2010cited by this paper
• TIA-1 Cytotoxic Granule-Associated RNA Binding Protein Improves the Prognostic Performance of CD8 in Mismatch Repair-Proficient Colorectal Cancer

  2010cited by this paper
• FOXP3+ regulatory T cells in the human immune system

  2010cited by this paper
• Differentiation of effector CD4 T cell populations (*).

  2010cited by this paper
• Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer.

  2009cited by this paper
• Intraepithelial effector (CD3+)/regulatory (FoxP3+) T-cell ratio predicts a clinical outcome of human colon carcinoma.

  2009cited by this paper
• Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor.

  2009cited by this paper
• A Meta-Analysis

  2009cited by this paper
• Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study.

  2007cited by this paper
• High prevalence of Foxp3 and IL17 in MMR-proficient colorectal carcinomas

  2007cited by this paper
• Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome

  2006cited by this paper
• Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self

  2005cited by this paper
• The relationship between tumour T-lymphocyte infiltration, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer

  2005cited by this paper
• The relationship between T-lymphocyte subset infiltration and survival in patients with prostate cancer

  2004cited by this paper
• Molecular mechanisms regulating Th1 immune responses.

  2003cited by this paper
• Role of DNA mismatch repair defects in the pathogenesis of human cancer.

  2003cited by this paper
• Future Treatment Perspectives

  2003cited by this paper
• The relationship between T-lymphocyte infiltration, stage, tumour grade and survival in patients undergoing curative surgery for renal cell cancer

  2003cited by this paper
• Tumor-specific immunological recognition of frameshift-mutated peptides in colon cancer with microsatellite instability.

  2003cited by this paper
• Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer.

  2003cited by this paper
• TNM residual tumor classification revisited

  2002cited by this paper
• CD8 lethargy in the absence of CD4 help

  2002cited by this paper
• Histopathological identification of colon cancer with microsatellite instability.

  2001cited by this paper
• CD4+ T Cell Help Impairs CD8+ T Cell Deletion Induced by Cross-presentation of Self-Antigens and Favors Autoimmunity

  1997cited by this paper
• Colorectal cancer

  1993cited by this paper
• Reduction of infarct size in patients with inferior infarction with intravenous glyceryl trinitrate. A randomised study.

  1983cited by this paper

• The Correlation of PBK Expression with an Immune-Activated Tumor Microenvironment and Outcome in Colorectal Cancer

  2026cites this paper
• Evaluation of Proton Minibeam Radiotherapy on Antitumor Immune Responses in a Rat Model of Glioblastoma

  2025cites this paper
• Distribution and prognostic value of T-cells in primary colorectal cancer and adjacent non-tumor mucosa in stage IV versus stage I-III patients.

  2025cites this paper
• Liver metastasis of colorectal cancer: Mechanism and clinical therapy (Review)

  2025cites this paper
• Transcriptome-Wide Analysis and Experimental Validation from FFPE Tissue Identifies Stage-Specific Gene Expression Profiles Differentiating Adenoma, Carcinoma In-Situ and Adenocarcinoma in Colorectal Cancer Progression

  2025cites this paper
• Identification of a group of 9-amino-acridines that selectively downregulate regulatory T cell functions through FoxP3

  2025cites this paper
• The Impact of Nutritional Status and Tumor-Infiltrating Lymphocytes (CD4+ and CD8+) on Chemotherapy Response in Colorectal Cancer Patients

  2025cites this paper
• Multimodal data integration for biologically-relevant artificial intelligence to guide adjuvant chemotherapy in stage II colorectal cancer

  2025cites this paper
• KCNC3 as a prognostic indicator and a predictive marker for immunotherapy in colorectal cancer

  2025cites this paper
• Chemoprevention of Colorectal Cancer—With Emphasis on Low-Dose Aspirin and Anticoagulants

  2025cites this paper
• New approach in Understanding Colorectal Cancer Immunosuppression and Immunotherapy-Based Strategies in the Treatment of Microsatellite Stable Colorectal Cancer

  2024cites this paper
• Response to Neoadjuvant Chemotherapy in Invasive Breast Cancer Predicted by CD4+, CD8+, and FOXP3+ Tumor-Infiltrating Lymphocytes

  2024cites this paper
• Tissue adaptation of CD4 T lymphocytes in homeostasis and cancer.

  2024cites this paper
• What is the relevance of FoxP3 in the tumor microenvironment and cancer outcomes?

  2024cites this paper
• The Clinicopathological Characteristics of Young-Onset Versus Adult-Onset Colorectal Cancer: A Tertiary Hospital-Based Study

  2024cites this paper
• Location matters: spatial dynamics of tumor-infiltrating T cell subsets is prognostic in colon cancer

  2024cites this paper
• Prognostic value of a modified‑immune scoring system in patients with pathological T4 colorectal cancer

  2024cites this paper
• The expression of CCL17 and potential prognostic value on tumor immunity in thyroid carcinoma based on bioinformatics analysis

  2024cites this paper
• A Longitudinal Dynamic Change in LMR Can Be a Biomarker for Recurrence in Fusobacterium Nucleatum-Positive Colorectal Cancer Patients

  2024cites this paper
• Dynamics of the immune microenvironment and immune cell PANoptosis in colorectal cancer: recent advances and insights

  2024cites this paper
• An immune suppressive tumor microenvironment in primary prostate cancer promotes tumor immune escape

  2024cites this paper
• Prognostic assessment of T‐cells in primary colorectal cancer and paired synchronous or metachronous liver metastasis

  2024cites this paper
• Immunoproteomics reveal different characteristics for the prognostic markers of intratumoral-infiltrating CD3+ T lymphocytes and immunoscore in colorectal cancer.

  2024cites this paper
• FOXP3+ regulatory T cells, mismatch repair proteins and BRAF V600E status in young-onset colorectal cancer.

  2024cites this paper
• Spatial distribution pattern of immune cells is associated with patient prognosis in colorectal cancer

  2024cites this paper
• The tumor immune microenvironment and T-cell-related immunotherapies in colorectal cancer

  2024cites this paper
• Evaluation of regulatory T-cells in cancer immunotherapy: therapeutic relevance of immune checkpoint inhibition

  2024cites this paper
• Identification of angiogenesis-related subtypes, the development of prognostic models, and the landscape of tumor microenvironment infiltration in colorectal cancer

  2023cites this paper
• Characteristics of ABCC4 and ABCG2 High Expression Subpopulations in CRC—A New Opportunity to Predict Therapy Response

  2023cites this paper
• Propolis Has an Anticancer Effect on Early Stage Colorectal Cancer by Affecting Epithelial Differentiation and Gut Immunity in the Tumor Microenvironment

  2023cites this paper
• Ultrastructural and morphological analysis during progression of Bowen disease reveals a complex interplay between hyperkeratosis, cytokeratin expression, host immunity and amyloid deposition

  2023cites this paper
• Case Report: Genetic and immune microenvironmental characteristics of a rectal cancer patient with MSS/PD-L1-negative recurrent hepatopulmonary metastasis who achieved complete remission after treatment with PD-1 inhibitor

  2023cites this paper
• Protein expression of S100A2 reveals it association with patient prognosis and immune infiltration profile in colorectal cancer

  2023cites this paper
• Impact of rapid hypertrophy of tourniquet associating liver partition and portal vein ligation in the tumor progression pathways compared to two stage hepatectomy in patients with colorectal liver metastases.

  2023cites this paper
• The predictive value of CD4, CD8, and C—reactive protein in the prognosis of schistosomal and non-schistosomal colorectal cancer

  2023cites this paper
• Relationship Between Infiltration of CD163+ TAMs, FoxP3+ Tregs, or CD66b+ TANs and Cell Differentiation in Colorectal Cancer Tissues

  2023cites this paper
• IL-6 Levels Correlate with Prognosis and Immunosuppressive Stromal Cells in Patients with Colorectal Cancer

  2023cites this paper
• Association of clinical outcomes and the predictive value of T lymphocyte subsets within colorectal cancer patients

  2023cites this paper
• Interleukins (Cytokines) as Biomarkers in Colorectal Cancer: Progression, Detection, and Monitoring

  2023cites this paper
• How to overcome resistance to immune checkpoint inhibitors in colorectal cancer: From mechanisms to translation

  2023cites this paper
• Construction of cuproptosis‑associated prognostic signature in colon adenocarcinoma based on bioinformatics and RT‑qPCR analysis

  2023cites this paper
• Prognostic impact of CD4+ and CD8+ tumor-infiltrating lymphocytes in patients with colorectal cancer

  2023cites this paper
• The immune microenvironment landscape shows treatment-specific differences in rectal cancer patients

  2022cites this paper
• Multiplexed single-cell analysis reveals prognostic and nonprognostic T cell types in human colorectal cancer

  2022cites this paper
• Cross-Talk Between m6A- and m5C-Related lncRNAs to Construct a Novel Signature and Predict the Immune Landscape of Colorectal Cancer Patients

  2022cites this paper
• Correlation and prognostic implications of intratumor and tumor draining lymph node Foxp3+ T regulatory cells in colorectal cancer

  2022cites this paper
• Preoperative skeletal muscle status is associated with tumor‐infiltrating lymphocytes and prognosis in patients with colorectal cancer

  2022cites this paper
• Bioinformatic Analysis of the Effect of Silver Nanoparticles on Colorectal Cancer Cell Line

  2022cites this paper
• Comprehensive evaluation of the tumor immune microenvironment and its dynamic changes in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy: From the phase II ADORE study

  2022cites this paper
• A Systematic Framework for Identifying Prognostic Genes in the Tumor Microenvironment of Colon Cancer

  2022cites this paper
• CD3D Is an Independent Prognostic Factor and Correlates With Immune Infiltration in Gastric Cancer

  2022cites this paper
• The efficient circulating immunoscore predicts prognosis of patients with advanced gastrointestinal cancer

  2022cites this paper
• Potentially functional genetic variants of the notch signaling pathway genes predict survival of Chinese patients with esophageal squamous cell carcinoma

  2022cites this paper
• Identi cation of Necroptosis-related Subtypes, Construction of a Prognosis Model, and Characterization of Immune In ltration in Colon Cancer

  2022cites this paper
• The Role of Tumor Microenvironment and Immune Response in Colorectal Cancer Development and Prognosis

  2022cites this paper
• Association of Tumor-infiltrating Lymphocytes (TILs) with Survival Depends on Primary Tumor Sidedness in Stage III Colon Cancers (NCCTG N0147) [Alliance].

  2022cites this paper
• A novel angiogenesis-based molecular signature related to prognosis and tumor immune interactions of pancreatic cancer

  2022cites this paper
• CD4 and FOXP3 as predictive markers for the recurrence of T3/T4a stage II colorectal cancer: applying a novel discrete Bayes decision rule

  2022cites this paper
• Type I and II interferon signaling in colorectal cancer liver metastasis.

  2022cites this paper
• Lung cancer patients with chronic obstructive pulmonary disease benefit from anti-PD-1/PD-L1 therapy

  2022cites this paper
• Identification of Spatial Proteomic Signatures of Colon Tumor Metastasis: A Digital Spatial Profiling Approach

  2022cites this paper
• Extensive Phenotypic Characterization of T Cells Infiltrating Liver Metastasis from Colorectal Cancer: A Potential Role in Precision Medicine

  2022cites this paper
• Effect of gut microbiota on colorectal cancer progression and treatment

  2022cites this paper
• Identification of immune cell infiltration landscape for predicting prognosis of colorectal cancer

  2022cites this paper
• Interplay of stromal tumor-infiltrating lymphocytes, normal colonic mucosa, cancer-associated fibroblasts, clinicopathological data and the immunoregulatory molecules of patients diagnosed with colorectal cancer

  2021cites this paper
• Lymphopenia and intratumoral lymphocytic balance in the era of cancer Immuno-Radiotherapy.

  2021cites this paper
• Comprehensive Characterization of Immunological Profiles and Clinical Significance in Hepatocellular Carcinoma

  2021cites this paper
• The Effects of Differentially-Expressed Homeobox Family Genes on the Prognosis and HOXC6 on Immune Microenvironment Orchestration in Colorectal Cancer

  2021cites this paper
• Identification of a novel immune signature for optimizing prognosis and treatment prediction in colorectal cancer

  2021cites this paper
• Identification of pyroptosis-related subtypes, the development of a prognosis model, and characterization of tumor microenvironment infiltration in colorectal cancer

  2021cites this paper
• Targeting of the tumor immune microenvironment by metformin

  2021cites this paper
• Cyclooxygenases and Prostaglandins in Tumor Immunology and Microenvironment of Gastrointestinal Cancer.

  2021cites this paper
• PU.1 is a nuclear factor of immunocompetent cells of tumor stroma in colorectal cancer

  2021cites this paper
• Lipidomic Typing of Colorectal Cancer Tissue Containing Tumour-Infiltrating Lymphocytes by MALDI Mass Spectrometry Imaging

  2021cites this paper
• [Effects of neoadjuvant chemoradiotherapy on infiltrating immune cells in the tumor microenvironment of rectal cancer].

  2021cites this paper
• Relationship between Fusobacterium nucleatum and antitumor immunity in colorectal cancer liver metastasis

  2021cites this paper
• Prognostic significance of CD163+ tumor-associated macrophages in colorectal cancer

  2021cites this paper
• DNA Methylation-Based Estimates of Circulating Leukocyte Composition for Predicting Colorectal Cancer Survival: A Prospective Cohort Study

  2021cites this paper
• Tumor necroptosis is correlated with a favorable immune cell signature and programmed death-ligand 1 expression in cholangiocarcinoma

  2021cites this paper
• Mechanisms of Immune Escape and Resistance to Checkpoint Inhibitor Therapies in Mismatch Repair Deficient Metastatic Colorectal Cancers

  2021cites this paper
• The role of FoxP3+ regulatory T cells and IDO+ immune and tumor cells in malignant melanoma – an immunohistochemical study

  2021cites this paper
• Changes in peripheral blood regulatory T cells, and IL-6 and IL-10 levels predict response of pediatric medulloblastoma and germ cell tumors with residual or disseminated disease to craniospinal irradiation.

  2021cites this paper
• The Colorectal Cancer Tumor Microenvironment and Its Impact on Liver and Lung Metastasis

  2021cites this paper
• Transcriptome of Tumor-Infiltrating T Cells in Colorectal Cancer Patients Uncovered a Unique Gene Signature in CD4+ T Cells Associated with Poor Disease-Specific Survival

  2021cites this paper
• KIF11 Serves as an Independent Prognostic Factor and Therapeutic Target for Patients With Lung Adenocarcinoma

  2021cites this paper
• An Efficient Prognostic Immune Scoring System For Colorectal Cancer Patients With Peritoneal Metastasis

  2021cites this paper
• A 3D View of Colorectal Cancer Models in Predicting Therapeutic Responses and Resistance

  2021cites this paper
• Immune System, Microbiota, and Microbial Metabolites: The Unresolved Triad in Colorectal Cancer Microenvironment

  2021cites this paper
• A nomogram-based immune-serum scoring system predicts overall survival in patients with lung adenocarcinoma

  2021cites this paper
• Tumor Immune Microenvironment Characteristics and Their Prognostic Value in Non-Small-Cell Lung Cancer

  2021cites this paper
• A Prognostic Immunoscore for Relapse-Free Survival Prediction in Colorectal Cancer

  2020cites this paper
• Prognostic value of tumor-infiltrating immune cells in primary colorectal cancer and metastases

  2020cites this paper
• Imaging Beyond Seeing: Early Prognosis of Cancer Treatment.

  2020cites this paper
• Identification of Significant Genes and Pathways in Acute Pancreatitis via Bioinformatical Analysis

  2020cites this paper
• Tumour budding in solid cancers

  2020cites this paper
• Prognostic Model of Colorectal Cancer Constructed by Eight Immune-Related Genes

  2020cites this paper
• Siglec-7 is a predictive biomarker for the efficacy of cancer vaccination against metastatic colorectal cancer

  2020cites this paper
• Quantitative assessment of tumor-infiltrating lymphocytes in mismatch repair proficient colon cancer

  2020cites this paper
• Differential gene expression of tumor-infiltrating CD4+ T cells in advanced versus early stage colorectal cancer and identification of a gene signature of poor prognosis

  2020cites this paper
• Multiple Immune Features-Based Signature for Predicting Recurrence and Survival of Inoperable LA-NSCLC Patients

  2020cites this paper